Atossa Therapeutics Faces Delisting Concerns
Ticker: ATOS · Form: 8-K · Filed: Feb 24, 2025 · CIK: 1488039
| Field | Detail |
|---|---|
| Company | Atossa Therapeutics, INC. (ATOS) |
| Form Type | 8-K |
| Filed Date | Feb 24, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory-filing
TL;DR
Atossa might get delisted - stock exchange rules are a problem.
AI Summary
Atossa Therapeutics, Inc. filed an 8-K on February 24, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard as of February 21, 2025. The company, incorporated in Delaware, is based in Seattle, Washington.
Why It Matters
This filing indicates potential issues with Atossa Therapeutics' compliance with stock exchange listing requirements, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's continued trading on an exchange.
Key Players & Entities
- Atossa Therapeutics, Inc. (company) — Registrant
- February 21, 2025 (date) — Date of earliest event reported
- February 24, 2025 (date) — Date of Report
- Seattle, Washington (location) — Principal Executive Offices
FAQ
What specific listing rule or standard has Atossa Therapeutics failed to satisfy?
The filing does not specify the exact rule or standard that Atossa Therapeutics has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
When was the earliest event reported that led to this notice?
The earliest event reported was on February 21, 2025.
What is Atossa Therapeutics' principal executive office address?
The principal executive offices are located at 10202 5th Avenue NE, Suite 200, Seattle, Washington 98125.
What is the company's IRS Employer Identification Number?
The IRS Employer Identification Number for Atossa Therapeutics, Inc. is 26-4753208.
Has the company's name changed previously?
Yes, the company was formerly known as Atossa Genetics Inc., with a date of name change on March 25, 2010.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 24, 2025 regarding ATOSSA THERAPEUTICS, INC. (ATOS).